Medical Treatment on Bening Prostatic Hyperplasia (BPH) with Combination Drug Therapy.

dc.contributor.author	Oliech, J. S.
dc.date.accessioned	2013-07-18T10:05:18Z
dc.date.available	2013-07-18T10:05:18Z
dc.date.issued	2011
dc.identifier.citation	J.S.OLIECH. Submitted. Medical Treatment on Bening Prostatic Hyperplasia (BPH) with Combination Drug Therapy.. East African Medical JOURNAL. : East African Medical Journal	en
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/48865
dc.description.abstract	Obective:To carry out an overview of the medical treatment of the benign prostatic hyperplasia using the combination drugs of alpha adrenergic uro-selective blockers(tamsulocin,alfuzocin) and the 5 alpha reductase iso-enzymes 1&2 inhibitor dutasteride . Data source :Review of researches don and those ongoing especially those sponsored and financed by GlaxoSmithcline in the multicenter international control trials. Data selction: Selected data from international researches on BPH from the following research groups MTOPS,PREDICT,PLESS,VCOOP,ALFIN,DUTASTERIDE 4-DATA 2004/PHASE 111a studies,COmbAT2007,SMART-1, also from GlaxoSmithkline data files.Data Extraction:Selection of research conclusions from various researches tested for clinical use by the international researchers.Data synthesis:From these the advantages of drug compliance on clinical use on BPH was analysed.	en
dc.language.iso	en	en
dc.title	Medical Treatment on Bening Prostatic Hyperplasia (BPH) with Combination Drug Therapy.	en
dc.type	Article	en
local.publisher	Department of Surgery, University of Nairobi	en